The Evidence
If you’re looking for a quick reference on the evidence, these resources are a great place to start. If you want to dive deeper or want more information on a specific topic, check out our Resource Library where you can explore by areas of interest.
The case for moving birth control pills over the counter in the United States is strong. In July 2023, the US Food and Drug Administration (FDA) approved Opill—a progestin-only birth control pill—for over-the-counter (OTC) use. Opill is now available online and in stores across the country, making it the first-ever OTC daily birth control pill in the United States.
There are two types of daily birth control pills: progestin-only birth control pills (POPs) and combined oral contraceptives (COCs). They are both safe and effective in preventing pregnancy.
The body of existing data demonstrates that these medications are suitable for OTC use and access—check out the studies below to learn more!